CDH1 and carcinoma: The graded loss expression of E-cadherin correlates with the aggressiveness of numerous carcinomas and the worsening of prognosis, whereas ectopic expression of E-cadherin suppresses tumor initiation and invasion in various in-vitro and in-vivo tumor model systems.